The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir). The warning describes potentially life-threatening cardiovascular side effects the drug is used with Norvir (ritonavir). Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230442.htm.
New safety information for Invirase
Most Recent Content
For Nurse Practitioners
Do Vitamins, Plants Help Uterine Fibroid Risk or Treatment?
A research team out of Poland recently undertook a comprehensive examination of published data to determine the role that vitamins and diet might play...
